Making the CaseMaking the Case: LEUKOMED® SORBACT®

Making the Case: LEUKOMED® SORBACT®

Acute wounds, Infection, Products

Making the Case: LEUKOMED® SORBACT®Surgical site infection (SSI) is the third most common type of healthcare-associated infection (HCAI), accounting for about 16% of all HCAIs; they are estimated to affect 6.4% of patients in healthcare systems in England (Health Protection Agency, 2011).